From THC Global Quarterly Update & Appendix 4C released today;
The terms of the facility allow for draw down of the $4 million immediately, with repayment on or before 31 October 2021 and attracts an interest rate of 1.25% per month on drawn funds paid monthly. Securing this funding enables the Company to continue its activities towards production of high quality price competitive TGA and EU GMP medicines for Australian patients and the global export market.
From THC Global Quarterly Update & Appendix 4C released...
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable